Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Hospital Pediatrics
|
March 19, 2026
Parental Attitudes Toward Inpatient Pediatric Vaccination
Tamara Gayle, Kathleen Webber, Katherine Finstuen-Magro, et al.
Cytotherapy
|
September 6, 2021
Spike-directed vaccination elicits robust spike-specific T-cell response, including to mutant strains
Maja Stanojevic, Ashley Geiger, Brita Ostermeier, et al.
Transplantation and Cellular Therapy
|
March 3, 2025
T Cell Immune Response to Influenza Vaccination When Administered Prior to and Following Autologous Chimeric Antigen Receptor-Modified T Cell Therapy
Hannah Kinoshita, Carla S Walti, Kathleen Webber, et al.
Molecular Therapy. Methods & Clinical Development
|
May 4, 2022
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products
Jessica Durkee-Shock, Christopher A Lazarski, Mariah A Jensen-Wachspress, et al.
Frontiers in Immunology
|
February 4, 2022
SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection
Susan R Conway, Christopher A Lazarski, Naomi E Field, et al.
Blood
|
December 17, 2020
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
Michael D Keller, Katherine M Harris, Mariah A Jensen-Wachspress, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Hospital Pediatrics
|
March 19, 2026
Parental Attitudes Toward Inpatient Pediatric Vaccination
Tamara Gayle, Kathleen Webber, Katherine Finstuen-Magro, et al.
Cytotherapy
|
September 6, 2021
Spike-directed vaccination elicits robust spike-specific T-cell response, including to mutant strains
Maja Stanojevic, Ashley Geiger, Brita Ostermeier, et al.
Transplantation and Cellular Therapy
|
March 3, 2025
T Cell Immune Response to Influenza Vaccination When Administered Prior to and Following Autologous Chimeric Antigen Receptor-Modified T Cell Therapy
Hannah Kinoshita, Carla S Walti, Kathleen Webber, et al.
Molecular Therapy. Methods & Clinical Development
|
May 4, 2022
Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products
Jessica Durkee-Shock, Christopher A Lazarski, Mariah A Jensen-Wachspress, et al.
Frontiers in Immunology
|
February 4, 2022
SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection
Susan R Conway, Christopher A Lazarski, Naomi E Field, et al.
Blood
|
December 17, 2020
SARS-CoV-2-specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
Michael D Keller, Katherine M Harris, Mariah A Jensen-Wachspress, et al.
Page
of 1